Novel Therapies in Primary Central Nervous System Lymphoma

Michel Wakim; Mariana Mezher; Ariel Perez-Perez; Arun Maharaj; Yazmin Odia; Manmeet S. Ahluwalia; Yuliya Linhares

doi:10.2147/CPAA.S501065

Novel Therapies in Primary Central Nervous System Lymphoma

Michel Wakim
, Mariana Mezher
, Ariel Perez-Perez
, Arun Maharaj
, Yazmin Odia
, Manmeet S. Ahluwalia
, Yuliya Linhares

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	97-117
Number of pages	21
Journal	Clinical Pharmacology: Advances and Applications
Volume	17
DOIs	https://doi.org/10.2147/CPAA.S501065
State	Published - 2025

ASJC Scopus Subject Areas

Pharmacology (medical)

Keywords

Bruton tyrosine kinase (BTK) signaling pathway in PCNSL
chimeric antigen receptor T cells (CARTs) in PCNSL
high-dose methotrexate (HD-MTX) in PCNSL
immunotherapy in PCNSL
primary central nervous system lymphoma (PCNSL)
targeted therapy in PCNSL

Access to Document

10.2147/CPAA.S501065

Cite this

@article{56c4296d37b648fc939af8e1b83803a3,

title = "Novel Therapies in Primary Central Nervous System Lymphoma",

keywords = "Bruton tyrosine kinase (BTK) signaling pathway in PCNSL, chimeric antigen receptor T cells (CARTs) in PCNSL, high-dose methotrexate (HD-MTX) in PCNSL, immunotherapy in PCNSL, primary central nervous system lymphoma (PCNSL), targeted therapy in PCNSL",

author = "Michel Wakim and Mariana Mezher and Ariel Perez-Perez and Arun Maharaj and Yazmin Odia and Ahluwalia, \{Manmeet S.\} and Yuliya Linhares",

note = "Publisher Copyright: {\textcopyright} 2025 Wakim et al.",

year = "2025",

doi = "10.2147/CPAA.S501065",

language = "English",

volume = "17",

pages = "97--117",

journal = "Clinical Pharmacology: Advances and Applications",

issn = "1179-1438",

}

TY - JOUR

T1 - Novel Therapies in Primary Central Nervous System Lymphoma

AU - Wakim, Michel

AU - Mezher, Mariana

AU - Perez-Perez, Ariel

AU - Maharaj, Arun

AU - Odia, Yazmin

AU - Ahluwalia, Manmeet S.

AU - Linhares, Yuliya

PY - 2025

Y1 - 2025

KW - Bruton tyrosine kinase (BTK) signaling pathway in PCNSL

KW - chimeric antigen receptor T cells (CARTs) in PCNSL

KW - high-dose methotrexate (HD-MTX) in PCNSL

KW - immunotherapy in PCNSL

KW - primary central nervous system lymphoma (PCNSL)

KW - targeted therapy in PCNSL

UR - https://www.scopus.com/pages/publications/105007577321

UR - https://www.scopus.com/pages/publications/105007577321#tab=citedBy

U2 - 10.2147/CPAA.S501065

DO - 10.2147/CPAA.S501065

M3 - Review article

C2 - 40454225

AN - SCOPUS:105007577321

SN - 1179-1438

VL - 17

SP - 97

EP - 117

JO - Clinical Pharmacology: Advances and Applications

JF - Clinical Pharmacology: Advances and Applications

ER -

Novel Therapies in Primary Central Nervous System Lymphoma

ASJC Scopus Subject Areas

Keywords

Access to Document

Other files and links

Cite this